Gaucher disease and bone: Laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy

By Ciana G.   Addobbati R.   Tamaro G.   Leopaldi A.   Nevyjel M.   Ronfani L.   Vidoni L.   Pittis M.   Bembi B.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 5, 2005-09 ,pp. : 723-732

Springer Publishing Company

Access to resources Recommend Favorite

Evoked potentails and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience

By Tantawy Azza   Sherif Eman   Adly Amira   Hassanine Sahar   Awad Amina  

Journal of Inherited Metabolic Disease, Vol. 36, Iss. 6, 2013-11 ,pp. : 1025-1037

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy

By Lo Sarah   Liu Jun   Chen F.   Pastores G.   Knowles J.   Boxer M.   Aleck Kirk   Mistry Pramod  

Journal of Inherited Metabolic Disease, Vol. 34, Iss. 3, 2011-06 ,pp. : 643-650

Springer Publishing Company

Access to resources Recommend Favorite

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report

By Martinez-Redondo C.   Ortuño F.   Lozano M.   Jerez A.   del Mar Osma M.   Giraldo P.   Vicente V.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite

EVALUATION OF BONE MINERAL DENSITY AT DIFFERENT PHASES OF THERAPY OF CHILDHOOD ALL

By Maniadaki Ilianna   Stiakaki Eftichia   Germanakis Ioannis   Kalmanti Maria  

Pediatric Hematology and Oncology, Vol. 23, Iss. 1, 2006-01 ,pp. : 11-18

Informa Healthcare

Access to resources Recommend Favorite